Investigational Site Number :6160007

Katowice, Silesian Voivodeship 40-684

0 studies enrolling now · 4 studies all time

What they study most

Cutaneous Lupus Erythematosus, Hidradenitis Suppurativa, Non-relapsing Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis

Studies at this site

• Primary Progressive Multiple Sclerosis (PPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (PERSEUS) — Completed
• A Phase 2 Study to Evaluate the Efficacy and Safety of SAR444656 Compared With Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa — Stopped early
• Proof of Concept Study of SAR443122 in Patients With Cutaneous Lupus Erythematosus — Completed
• Nonrelapsing Secondary Progressive Multiple Sclerosis (NRSPMS) Study of Bruton's Tyrosine Kinase (BTK) Inhibitor Tolebrutinib (SAR442168) (HERCULES) — Completed